Safety and efficacy of the RTS, S/AS01 E candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trial

Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Search UGSpace


Browse

My Account